Suppr超能文献

心脏手术中的床旁血细胞比容和血红蛋白:综述

Point of care hematocrit and hemoglobin in cardiac surgery: a review.

作者信息

Myers Gerard J, Browne Joe

机构信息

Cardiovascular Perfusion, QEII & IWK Health Science Centers, Halifax, Nova Scotia, Canada.

出版信息

Perfusion. 2007 May;22(3):179-83. doi: 10.1177/0267659107080826.

Abstract

The use of point-of-care blood gas analyzers in cardiac surgery has been on the increase over the past decade. The availability of these analyzers in the operating room and post-operative intensive care units eliminates the time delays to transport samples to the main laboratory and reduces the amount of blood sampled to measure such parameters as electrolytes, blood gases, lactates, glucose and hemoglobin/hematocrit. Point-of-care analyzers also lead to faster and more reliable clinical decisions while the patient is still on the heart lung machine. Point-of-care devices were designed to provide safe, appropriate and consistent care of those patients in need of rapid acid/base balance and electrolyte management in the clinical setting. As a result, clinicians rely on their values to make decisions regarding ventilation, acid/base management, transfusion and glucose management. Therefore, accuracy and reliability are an absolute must for these bedside analyzers in both the cardiac operating room and the post-op intensive care units. Clinicians have a choice of two types of technology to measure hemoglobin/hematocrit during bypass, which subsequently determines their patient's level of hemodilution, as well as their transfusion threshold. All modern point-of-care blood gas analyzers measure hematocrit using a technology called conductivity, while other similar devices measure hemoglobin using a technology called co-oximetry. The two methods are analyzed and compared in this review. The literature indicates that using conductivity to measure hematocrit during and after cardiac surgery could produce inaccurate results when hematocrits are less than 30%, and, therefore, result in unnecessary homologous red cell transfusions in some patients. These inaccuracies are influenced by several factors that are common and unique to cardiopulmonary bypass, and will also be reviewed here. It appears that the only accurate, consistent and reliable method to determine hemodilution and establish transfusion thresholds based on nadir hematocrits during cardiopulmonary bypass, and immediately post cardiac surgery, is with the use of co-oximetry.

摘要

在过去十年中,心脏手术中即时检验血气分析仪的使用一直在增加。这些分析仪在手术室和术后重症监护病房的配备,消除了将样本运送到主实验室的时间延迟,并减少了为测量电解质、血气、乳酸、葡萄糖和血红蛋白/血细胞比容等参数而采集的血量。即时检验分析仪还能在患者仍在心肺机上时做出更快、更可靠的临床决策。即时检验设备旨在为临床环境中需要快速酸碱平衡和电解质管理的患者提供安全、适当和一致的护理。因此,临床医生依靠这些值来做出关于通气、酸碱管理、输血和葡萄糖管理的决策。因此,对于心脏手术室和术后重症监护病房的这些床边分析仪来说,准确性和可靠性是绝对必要的。临床医生在体外循环期间测量血红蛋白/血细胞比容有两种技术可供选择,这随后决定了患者的血液稀释程度以及输血阈值。所有现代即时检验血气分析仪都使用一种称为电导率的技术来测量血细胞比容,而其他类似设备则使用一种称为共血氧定量法的技术来测量血红蛋白。本文对这两种方法进行了分析和比较。文献表明,在心脏手术期间及术后使用电导率测量血细胞比容时,当血细胞比容低于30%时可能会产生不准确的结果,因此,在一些患者中会导致不必要的同源红细胞输血。这些不准确之处受到体外循环常见和特有的几个因素的影响,本文也将对此进行综述。看来,在体外循环期间以及心脏手术后立即确定血液稀释并基于最低点血细胞比容建立输血阈值的唯一准确、一致和可靠的方法是使用共血氧定量法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验